Nucleic Acids Research Advance Access published May 24, 2016 Nucleic Acids Research, 2016 1 doi: 10.1093/nar/gkw474 The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation Christopher Tiedje1,*,†, Manuel D. Diaz-Munoz˜ 2,*,†, Philipp Trulley1, Helena Ahlfors2, Kathrin Laa§1, Perry J. Blackshear3, Martin Turner2 and Matthias Gaestel1
1Institute of Physiological Chemistry, Medical School Hannover (MHH), 30625 Hannover, Germany, 2Lymphocyte Signalling and Development, The Babraham Institute, Cambridge CB22 3AT, UK and 3Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA; and Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, NC 27710, USA
Received January 29, 2016; Revised May 13, 2016; Accepted May 16, 2016 Downloaded from ABSTRACT fine-tuned TTP activity-regulation by MK2 in order to control the pro-inflammatory response. RNA-binding proteins (RBPs) facilitate post- transcriptional control of eukaryotic gene ex- pression at multiple levels. The RBP tristetraprolin INTRODUCTION / http://nar.oxfordjournals.org/ (TTP Zfp36) is a signal-induced phosphorylated RNA-binding proteins (RBPs) constitute an important anti-inflammatory protein guiding unstable mRNAs group of post-transcriptional regulators in diverse cellu- of pro-inflammatory proteins for degradation and lar processes acting on both coding and non-coding RNAs preventing translation. Using iCLIP, we have iden- (1,2). A prominent role for the post-transcriptional con- tified numerous mRNA targets bound by wild-type trol by RBPs is emerging especially in the regulation of in- TTP and by a non-MK2-phosphorylatable TTP mutant nate immunity (3). In this context the RBP tristetraprolin (TTP-AA) in 1 h LPS-stimulated macrophages and (TTP), encoded by the Zfp36 gene of the Tis11-family, acts on pro-inflammatory cytokine mRNAs. It guides them for correlated their interaction with TTP to changes at BBSRC on June 8, 2016 / at the level of mRNA abundance and translation degradation and or prevents their efficient translation4 ( ). This function depends on the RNA helicase Ddx6 (5)or in a transcriptome-wide manner. The close simi- the 4EHP-GYF complex (6). Distinct sequences such as larity of the transcriptomes of TTP-deficient and AU-rich elements (AREs) in the 3 UTRs of mRNAs reg- TTP-expressing macrophages upon short LPS stim- ulate their stability by serving as binding platforms for TTP ulation suggested an effective inactivation of TTP (7). During inflammatory conditions triggered by TLR4- by MK2, whereas retained RNA-binding capacity mediated activation of macrophages with lipopolysaccha- of TTP-AA to 3UTRs caused profound changes in ride (LPS), these mRNAs are stabilized and their transla- the transcriptome and translatome, altered NF-B- tion is preferentially enhanced (8). The molecular switch activation and induced cell death. Increased TTP for this regulation relies on the phosphorylation of TTP MAPK binding to the 3UTR of feedback inhibitor mRNAs, by p38 -activated protein kinase 2 (MAPKAPK2 or such as Ier3, Dusp1 or Tnfaip3, in the absence of MK2) at two conserved serine residues (S52 and S178 in MK2-dependent TTP neutralization resulted in a mouse, S60 and S186 in human) (9). This phosphorylation results in a sequestration of TTP by 14-3-3 proteins prevent- strong reduction of their protein synthesis con- ing its mRNA degrading activity (10) and might change tributing to the deregulation of the NF- B-signaling TTP’s RNA affinity to AREs (8). A phosphorylation- pathway. Taken together, our study uncovers a sensitive interaction of TTP with components of the Ccr4- role of TTP as a suppressor of feedback inhibitors Not1-deadenylation complex (11–13) and enhanced re- of inflammation and highlights the importance of placement of phospho-TTP by translation-promoting fac- tors (8) was additionally shown. To better understand the global regulatory potential of TTP and the consequences of
*To whom correspondence should be addressed. Tel: +49 511 5329466; Fax: +49 511 532161046; Email: [email protected] Correspondence may also be addressed to Manuel D. Diaz-Munoz.˜ Tel: +44 1223 496155; Fax: +44 7825 884241; Email: manuel.diaz- [email protected] † These authors contributed equally to this work as First Authors.